z-logo
Premium
Proteinase inhibitors from Streptomyces with antiviral activity
Author(s) -
Serkedjieva Julia,
Angelova Lidiya,
Remichkova Mimi,
Ivanova Iskra
Publication year - 2006
Publication title -
journal of basic microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.58
H-Index - 54
eISSN - 1521-4028
pISSN - 0233-111X
DOI - 10.1002/jobm.200510127
Subject(s) - virus , microbiology and biotechnology , biology , proteases , herpes simplex virus , streptomyces , protease , virology , influenza a virus , strain (injury) , enzyme , bacteria , biochemistry , genetics , anatomy
An extensive screening study for the production of proteolytic inhibitors has been carried out on 75 Streptomyces strains. It was found that 18 of the strains and/or their variants (24%) produced proteinaceous substances, which belonged to the group of typical serine protease inhibitors. 23 samples were tested for inhibitory activity on the replication of influenza virus A/Germany/34, strain Rostock (H7N1) (A/Rostock) in chicken embryonic fibroblast (CEF) cells. Eleven of the tested samples (52.2%) significantly inhibited viral growth. Further the specific inhibitory effect on the replication of influenza virus A/Aichi/2/68 (H3N2) (A/Aichi) in Madin‐Darby canine kidney (MDCK) cells and on the growth of herpes simplex virus type 1, strain DA (HSV‐1) in Madin‐Darby bovine kidney (MDBK) cells was tested. Nine samples significantly inhibited A/Aichi and four – HSV‐1. The most effective inhibitors, produced by Streptomyces sp. 225b (SS 225b) and Streptomyces chromofuscus 34‐1 (SS 34‐1) protected mice from mortality in the experimental influenza A/Aichi virus infection. (© 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom